Reliability and accuracy of point-of-care amino-terminal probrain natriuretic peptide in congestive heart failure patients

Internet Journal of Cardiology

Volumn 9, Issue 2, 2010, Pages 2-

  Ajuluchukwu, J N A ^a   Ekure, E N ^a   Mbakwem, A C ^a   Okoromah, C N ^a   Oladipo, O O ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Amino terminal pro bnp; Congestive heart failure; Diagnostic accuracy; Oint of care

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMMUNOASSAY; MALE; NIGERIA; POINT OF CARE TESTING; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

EID: 78649792152     PISSN: None     EISSN: 1528834X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Adams KF, Lindenfeld J, Arnold JMO, Baker DW, Barnard DH, Baugham KL et al. Executive Summary HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Cardac Fail 2006; 12: 10-38
2. Dickstein K and Task Force Members. Heart Failure Guidelines for Treatment of Acute and Chronic Heart Failure. ESC Pocket Guidelines. Europ Heart J. 2008; doi; 10: 1093
3. Purcell IF, Poole Wilson PA. Heart Failure: Why and How to Define It. Europ J Heart Fail. 1997; 1: 7-10.
4. Hobbs FDR, Davis RC, Roalfe AK, Hare R, Davies MK, Kenkre JE. Reliability of N-Terminal Pro-Brain Natriuretic Peptide Assay in the Diagnosis of Heart Failure: Cohort Study in Representative and High risk Community Populations. BMJ 2005; 324:1498-1504.
5. Mbakwem AC, Ajuluchukwu JNA. Survey of Primary Care Physicians' Perceptions on Diagnosis and Management of Congestive Heart Failure in Lagos. Nig Qrt J Hosp med. 2004; 4: 130-135
6. Gustafsson F, Steensgard-Hansen F, Badskjoer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and Prognostic Performance of N-Terminal Pro-BNP in Primary Care Patients With Suspected Heart Failure. J Heart Fail 2005; 11 (Suppl): S15-S20.
7. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PWF, Levy D. Plasma Natriuretic Peptides for Community Screening for Left Ventricular and Systolic Dysfunction. JAMA 2002; 288: 1252-1259.
8. Davies MK, Hobbs FDR, Davis RC, Kenkre JE, Roalfe AK, Hare R, Wosornu D, Lancashire RJ. Prevalence of Left Ventricular Systolic Dysfunction and Heart Failure in the Echocardiographic Heart of England Screening Study: a Population Based Study. Lancet 2001; 358: 439-44.
9. Jose JV, Gupta SN, Selvakumar D. Utility of N Terminal Pro-BNP for the Diagnosis of Heart Failure. Indian Heart J 2003; 55: 1-9
10. Chakko S, Woska D, Martinez H, de Marchena E, Futterman L, Kessler K et al. Clinical, Radiographic and Haemodynamic Correlations in Congestive Heart Failure: Conflicting Results May Lead to Inappropriate Care. Am J Med 1991; 90: 353-359.
11. Hall C. NT Pro BNP: The Mechanism Behind the Marker J Cardiac Fail 2005; 5: suppl S81-S83.
12. Yeo KJ, Dumont K, Brough T. Elecsys NT pro-BNP and BNP Assays: Are There Analytically and Clinically Relevant Differences? J Cardiac Fail 2005; 11 Suppl 84-87.
13. O'Donoghue M, Chen A, Baggish I, Anwaruddin S, Krausser DG, Tung RT. et al. The Effects of Ejection Fraction on N-Terminal Pr-BNP and BNP Levels in Patients with Acute Heart Failure: Analysis From the Pro-BNP Investigation of Dyspnoea in an Emergency Department (PRIDE). J Cardiac Fail 2005; s90-s114
14. Yancy C, Fowler MB, Collucci WS, Gilbert EM, Bristow MR, Cohn JN et al. Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure. N Engl J Med 2001; 344: 1358-1365
15. McNamara DM, Tam W, Sabolinski ML, Tobelman P, Janosko K, Venkitachalam L et al. Endothelial Nitric oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A'HEFT Trial. J Cardiac Fail 2009; 15: 191-198.
16. Montagnana M, Lippi G, Salvagno GL, Guidi GC. Reference Ranges and Diagnostic Thresholds of Laboratory Markers of Cardiac Damage and Dysfunction in a Population of Apparently Healthy Black Africans. Clin Chem Lab Med 2008; 46: 714-718
17. Abdulle AM, Nagelkerke NJD, Adem A, Abuchacra A, Pathan JY, Al-Rukhaimi M, et al. Plasma N terminal pro-Brain Natriuretic Peptide Levels and its Determinants in a Multi-Ethnic Population. J Human Hypertens 2007; 21: 647-653
18. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholis MG, Richards AM. Treatment of Heart Failure Guided by Plasma Aminoterminal Brain Natriuretic Peptide Concentrations. Lancet 2000; 355: 1126-30.
19. Grimes DA, Schulz KF. Uses and Abuses of Screening Tests. Lancet 2002; 359: 881-884
20. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of Heart Disease and Risk Factors in a Black Urban Population in South Africa. The Lancet 2008; 371: 915-22.
21. McDonough T, Holmer S, Raymond I, Luchner A, Hilderbrent P, and Dargie HJ. NT Pro- BNP and Diagnosis of Heart Failure: a Pooled Analysis of Three European Epidemiological Studies. Europ J Heart Fail 2004; 6: 269-273.
22. Nielsen OW, Kirkn V, Bay M, Boesgaard S., Nielsen H. Value of N-terminal Pro Brain Natriuretic Peptide in the Elderly: data From the Prospective Copenhagen Hospital Heart failure Study (CHHF). Europ J Heart Fail 2004; 6:275-279.